Anavex Life Sciences Corp (AVXL)

[falconer66a]

But, only trial outcomes count.

But, what can it prove if the patient (or his advisors) think the drug is working? or just thinks it is advisable to continue, working or not.

Our amiable conversations about being able to determine the drug's efficacies while the blinded trial continues are merely that, conversations.

The only thing that counts are statistical outcomes data generated in the study. Those, alone, will determine FDA approval.

Personally, based on the Phase I GABA results, in consideration of the involved nerve physiology modulated by GABA, I'm very confident the Phase 3 data will be further, stronger validations of those in Phase 1. FDA approval will follow.